News-Medical.Net on MSN
Researchers identify chromatin accessibility changes driving stem cell transformation in MDS
Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...
In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease recurs after treatment or fails to respond, CAR ...
As a kidney transplant recipient, Paris Malachias was accustomed to dealing with skin cancer. But when a biopsy showed that ...
The program subsidizes schools to develop courses on non-animal alternative models, including 3D mapping, digital imaging, ...
Since taking over the Sayville Theater in 2023, the Fickling family has spent a “couple hundred thousand dollars” on ...
News-Medical.Net on MSN
Preoperative radiation may enhance treatment response in patients with HR-positive, HER2-negative breast cancer
Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative ...
Shreveport Times on MSN
CDC report finds Louisiana gun violence one of worst in nation. See rank
Louisiana has the second-highest rate of gun-related deaths in the U.S., with a total of 1,261 deaths involving a firearm ...
University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is ...
19hon MSN
Homeland Security Secretary Noem faces scrutiny over immigration policies at a House hearing
WASHINGTON (AP) — Homeland Security Secretary Kristi Noem, who heads the agency central to President Donald Trump’s mass ...
16hon MSN
Bulgaria’s government resigns after mass protests and just weeks before nation due to join eurozone
SOFIA, Bulgaria (AP) — Bulgaria’s government resigned on Thursday after mass protests gripped the country and just weeks ...
Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...
Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results